Skip to main content
. 2022 May 23;45(1):77–83. doi: 10.1590/2175-8239-JBN-2021-0250en

Table 3. Gonadotropic axis and homa-ir characteristics according to sex at 1 and 12 months after kidney Transplantation.

Women (n=12) Men (n=13)
At 1 month after KT At 12 months after KT At 1 month after KT At 12 months after KT
LH (mcIU/mL); M (IQR) 7.8 (4.7-18.6) 12.5 (5.9-20.3) 6.8 (4.7-10.8) 5.5 (4.3-12.5)
FSH (mcIU/mL); M (IQR) 4.4 (2.8-8.7) 5.5 (3.5-8.7) 4.6 (4.1-12.8) 5.6 (3.9-9.6)
Gonadal Steroids; M (IQR)
Estradiol (in women) (pg/mL) 60.2 (5-67) 60.4 (42-203)* 354 (266-503) 457 (394-568) *
Testosterone (in men) (ng/dL)
Prolactin (ng/mL); M (IQR) 17.9 (14.2-24.6) 19.3 (15.6-23) 18.6 (14.3-22.3) 17.7 (16.3-21.9)
Hypogonadism; % (n) 33 (4) 17 (2) * 38 (5) 0 *
Type of hypogonadism; % (n)
Hypogonadotropic hypogonadism 17 (2) 17 (2) 0 0
Hypergonadotropic hypogonadism 25 (3) 0 38.5 (5) 0
HOMA-IR; M (IQR) 1.97 (1.38-2.65) 2.02 (1.46-2.73) 2.80 (2.31-3.59 2.3 (1.74-3.01)
Insulin resistance; % (n) 42 (5) 33(4) 69(9) 38(5)
*

p<0.05; SD: standard deviation, M: median; IQR: interquartile range; KT: kidney transplantation.